Kelly Teske

Kelly Teske, PhD, is a Senior Research Scientist 1 at Promega Corporation, a position held since July 2021. Previously, Kelly served as an Assistant Professor of Chemistry at Western Michigan University from August 2018 to July 2021 and worked as a Postdoctoral Fellow at the University of Connecticut from November 2015 to June 2018, focusing on the development of azole antifungal analogues for treating medulloblastoma. In addition to research roles, Kelly has extensive teaching experience, including positions as an Adjunct Professor at the University of Connecticut and a Research Assistant at the University of Wisconsin Milwaukee, where projects involved designing Vitamin D Receptor modulators. Educational credentials include a Ph.D. in Organic Chemistry, Medicinal Chemistry, and Biochemistry from the University of Wisconsin-Milwaukee and a B.S. in Chemistry and Biochemistry & Molecular Biology from Illinois State University.